CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Chat-based supportWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (10)


Name (Synonyms) Correlation
drug1141 Hypothermia Wiki 1.00
drug98 AWARD advice Wiki 1.00
drug2161 SMS-based support Wiki 1.00
drug444 COSH Self-help smoking cessation booklet Wiki 1.00
drug1039 Health warning leaflet Wiki 1.00
drug2052 Referral card Wiki 1.00
drug1584 Neuromuscular Blocking Agents Wiki 1.00
drug481 COVID-19 related health warning leaflet Wiki 1.00
drug99 AWARD plus COVID-specific advice Wiki 1.00
drug2319 Standard of Care Wiki 0.20

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D007035 Hypothermia NIH 1.00
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002045 Hypothermia HPO 1.00

There is one clinical trial.

Clinical Trials


1 Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2020: a Single-blind Randomized Controlled Trial on COVID-19 Related Brief Advice and Personalized Chat-based Intervention for Smoking Cessation

The present study will examine (1) the effectiveness of a combined brief advice and personalized chat-based support on COVID-19 related smoking messages and (2) explore the use of CBPR model to build capacity and to engage community partners in taking on this important public health issue for sustainability in the community. In addition, a process evaluation will be conducted to assess the effectiveness of the recruitment activity and how it is linked with the overall program outcomes.

NCT04399967 Smoking Cessation Behavioral: Chat-based support Behavioral: AWARD plus COVID-specific advice Behavioral: AWARD advice Behavioral: COVID-19 related health warning leaflet Behavioral: Health warning leaflet Behavioral: SMS-based support Behavioral: Referral card Behavioral: COSH Self-help smoking cessation booklet

Primary Outcomes

Description: The primary outcomes are biochemically validated quit rates (exhaled CO < 4 ppm and salivary cotinine < 30 ng/ml) at 3-month in the two groups

Measure: Biochemical validated quit rate

Time: 3-month follow-up

Description: The primary outcomes are biochemically validated quit rates (exhaled CO < 4 ppm and salivary cotinine < 30 ng/ml) at 6-month in the two groups

Measure: Biochemical validated quit rate

Time: 6-month follow-up

Secondary Outcomes

Description: Self-reported 7-day point prevalence (pp) quit rate at 3-month between the two groups

Measure: Smoking quit rate change from baseline at 3-month follow-up

Time: 3-month follow-up

Description: Self-reported 7-day point prevalence (pp) quit rate at 6-month between the two groups

Measure: Smoking quit rate change from baseline at 6-month follow-up

Time: 6-month follow-up

Description: Rate of smoking reduction by at least half of baseline amount in the two groups

Measure: Smoking reduction rate change from baseline at 3-month follow-up

Time: 3-month follow-up

Description: Rate of smoking reduction by at least half of baseline amount in the two groups

Measure: Smoking reduction rate change from baseline at 6-month follow-up

Time: 6-month follow-up

Description: Number of quit attempts at 3-month in the two groups

Measure: Smoking quit attempt change from baseline at 3-month follow-up

Time: 3-month follow-up

Description: Number of quit attempts at 6-month in the two groups

Measure: Smoking quit attempt change from baseline at 6-month follow-up

Time: 6-month follow-up

Description: Use of smoking cessation at 3 and 6 month follow-up in the two groups

Measure: Use of smoking cessation service

Time: 3 and 6 months follow-up

Description: Self-reported engagement in chat-based support in the two groups

Measure: Engagement in chat-based support

Time: 3 and 6 months follow-up


No related HPO nodes (Using clinical trials)